Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview

Version 1 : Received: 19 February 2024 / Approved: 20 February 2024 / Online: 20 February 2024 (11:46:19 CET)

How to cite: Sanchini, A.; Lanni, A.; Giannoni, F.; Mustazzolu, A. Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview. Preprints 2024, 2024021123. https://doi.org/10.20944/preprints202402.1123.v1 Sanchini, A.; Lanni, A.; Giannoni, F.; Mustazzolu, A. Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview. Preprints 2024, 2024021123. https://doi.org/10.20944/preprints202402.1123.v1

Abstract

Despite available global efforts and funding, Tuberculosis (TB) continues to affect a considerable number of patients worldwide. Policy makers and stakeholders set clear goals to reduce TB incidence and mortality, but the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) complicate the reach of these goals. Drug-resistance TB needs to be diagnosed rapidly and accurately to effectively treat patients, prevent the transmission of MDR-TB, minimise mortality, reduce treatment costs and avoid unnecessary hospitalisations. In this narrative review, we provide a comprehensive overview of laboratory methods for detecting drug resistance in MTB, focusing on phenotypic, molecular and other drug susceptibility testing (DST) techniques. We found a large variety of methods used, with the BACTEC MGIT 960 being the most common phenotypic DST and the Xpert MTB/RIF being the most common molecular DST. We emphasise the importance of integrating phenotypic and molecular DST to address issues like resistance to new drugs, heteroresistance, mixed infections and low-level resistance mutations. Notably, most of the analysed studies adhered to the outdated definition of XDR-TB and did not consider the pre-XDR definition, thus posing challenges in aligning diagnostic methods with the current landscape of TB resistance.

Keywords

Mycobacterium tuberculosis; multidrug-resistant; extensively drug-resistant; diagnostic methods; point-of-care; phenotypic methods; molecular methods; drug resistance detection; rapid test

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.